New Frontiers in Psychedelic Research: Iboga Microdosing with Dr. Burton J. Tabaac & Teresa Yung

Ibogaine is evaluated in a case series investigating its microdosing protocol for treating post-concussive and hypoxic ischemic brain injuries. This clinical exploration highlights how microdosing ibogaine within a therapeutic container can address various complex symptoms while avoiding the intensity of larger, traditional psychedelic doses. This research emphasizes individual patient needs, the importance of psychological support, and the role of neuroplasticity in recovery. Furthermore, the discussion highlights the shift towards viewing the brain, mind, and body as an integrated system in treatment, moving beyond the traditional separation of neurology and psychiatry. This systemic approach is complemented by the use of therapeutic techniques to address underlying trauma, showcasing a promising evolution in how psychedelic medicine can be applied to clinical outcomes.